Abu Eid, Rasha2019-03-192019-03-192019-03-19Abu Eid, R 2019, 'Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy', Frontiers in Oncology, vol. 9, 172. https://doi.org/10.3389/fonc.2019.001722234-943XMendeley: fd47829b-1cd4-3ff8-b1ef-4225dbfa815ehttp://hdl.handle.net/2164/12062153251engSDG 3 - Good Health and Well-beinghead and neck cancercancer immunologyimmunotherapyimmune check point inhibitorcancer vaccineregulatory T (Treg) cellhuman leukocyte antigenERK1/2OsteosarcomaMYCOncogeneDGKZRK DentistryOncologyCancer ResearchRKJournal item10.3389/fonc.2019.00172http://www.scopus.com/inward/record.url?scp=85063346095&partnerID=8YFLogxKhttp://www.mendeley.com/research/dgkz-acts-potential-oncogene-osteosarcoma-proliferation-through-possible-interaction-erk12-myc-pathw9